Publication:
Rapid improvement in visual loss with cabergoline treatment in a giant prolactinoma case: 5 years survey

No Thumbnail Available
Date
2015-01-01T00:00:00Z
Authors
Tasan, ERTUĞRUL
HANIMOGLU, Hakan
Turgut, SEDA
Ilhan, MAHMUT MUZAFFER
EVRAN, Sevket
KAYNAR, Mehmet Yasar
Journal Title
Journal ISSN
Volume Title
Publisher
Research Projects
Organizational Units
Journal Issue
Abstract
Giant prolactinoma is a rare subset of macroadenomas. Limited studies demonstrated which therapy could be successfully used in the first-line therapy of giant prolactinoma. We presented a case with a 54x40x40 mm pituitary adenoma and optic chiasmatic compression with left sphenoid sinus invasion. The tumor caused a loss of visual field of the right side. Cabergoline treatment was started with dose of 1.5 mg/week. Fifteen days later, the clinical visual acuity examination showed a significant improvement in the patient with visual field defect. After the five years follow-up magnetic resonance imagining showed reduction of the adenoma size (17x12 mm) was significant. Our findings suggest that, cabergoline can be used as a first-line therapy in giant prolactinomas because tumoral shrinkage without a surgical procedure and rapid improvement in visual field defect is achieved with this medical treatment.
Description
Keywords
Citation
Tasan E., HANIMOGLU H., Turgut S., Ilhan M. M. , EVRAN S., KAYNAR M. Y. , -Rapid improvement in visual loss with cabergoline treatment in a giant prolactinoma case: 5 years survey-, NEUROENDOCRINOLOGY LETTERS, cilt.36, ss.28-30, 2015
Sustainable Development Goals